We will rely on you to help lend your voice and support the biotechnology industry.
Learn more about BIO initiatives to advance the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO CEO & Investor Conference
February 12-13, 2018
BIO IP Counsels Committee Conference
April 11-13, 2018
BIO Industry Analysis Reports
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
July 16 - 19, 2018 | Philadelphia, Pennsylvania
Stephan Herrera is VP, Strategy & Public Affairs at Basel, Switzerland-based Evolva, which is brewing up next-gen health, wellness, and nutrition ingredients via yeast fermentation. Herrera is based in Evolva's Bay Area office.
Prior to Evolva, Herrera worked in IR/PR at Nektar Therapeutics and Sirna Therapeutics.
Prior to his operational roles in biotech, Herrera was a reporter and editor who specialized in the global business, science and politics of biotechnology, industrial biotech, and nanotechnology, holding staff reporting & editing gigs at leading magazines such as Forbes, Red Herring, and Nature Biotechnology. He was also a longtime contributor to the Economist and a contributing editor at MIT Technology Review.
This speaker's sessions: